IM007 vs KardiaPro

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Implicity
VS
by AliveCor

AI Verdict

Both IM007 and KardiaPro are FDA-cleared, AI-powered, cloud-based platforms for remote cardiac monitoring, making them direct competitors. IM007 specializes in aggregating data from various cardiac implantable electronic devices (CIEDs) and offers advanced AI for reducing false alerts and predicting heart failure risk, while KardiaPro focuses on managing ECG, blood pressure, and weight data, integrating seamlessly with its KardiaMobile devices for arrhythmia detection.

Choose IM007 if…

Choose Implicity (IM007) if your cardiology practice or hospital system manages a large patient population with various cardiac implantable electronic devices (CIEDs) from multiple manufacturers. Its AI-powered platform excels at unifying data from diverse devices, reducing false alerts, and automating workflows for efficient, high-volume remote monitoring and improved patient outcomes, including a demonstrated reduction in mortality and hospitalizations for ICD patients.

View IM007 →

Choose KardiaPro if…

Choose KardiaPro if your practice focuses on comprehensive remote monitoring of patients using personal ECG devices like KardiaMobile, along with blood pressure and weight data. This web-based portal is ideal for efficiently reviewing patient-initiated ECGs, detecting arrhythmias with FDA-cleared AI, and tracking longitudinal cardiac patterns to inform clinical decisions between appointments.

View KardiaPro →

When choosing between IM007 by Implicity and KardiaPro by AliveCor, cardiologists should consider their primary focus in remote patient monitoring. IM007 excels in managing data from a wide array of cardiac implantable electronic devices (CIEDs), including those from major manufacturers like Abbott, Medtronic, and Boston Scientific. Its AI-driven alert management significantly reduces false positives, streamlining workflows for practices heavily involved in CIED follow-up. IM007 also offers specialized AI for ILR ECG analysis and predictive AI for heart failure hospitalization risk, making it ideal for practices with a high volume of complex cardiac device patients and those focused on advanced heart failure management.

KardiaPro, on the other hand, is a comprehensive web-based portal primarily designed for remote monitoring of patient-generated ECG, blood pressure, and weight data, seamlessly integrating with AliveCor’s KardiaMobile devices. Its FDA-cleared AI for arrhythmia detection and customizable ECG inbox are well-suited for practices managing a broader spectrum of cardiac patients, including those with less complex arrhythmias or general cardiovascular risk factors. The key practical difference lies in their data sources: IM007 centralizes data from implanted devices, while KardiaPro focuses on external, patient-recorded data. Therefore, a physician whose practice centers on managing patients with CIEDs and advanced heart failure would likely find IM007 more beneficial, while a physician managing a wider range of cardiac patients with a focus on patient-recorded data would lean towards KardiaPro.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature IM007 KardiaPro
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based SaaS Cloud-hosted, Web-based
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools offer cloud-based, web portals designed for efficient remote monitoring. KardiaPro highlights a comprehensive dashboard and customizable ECG inbox for efficient data review, while Implicity emphasizes a unified platform for all CIED data and smart workflow automation. Without direct user experience comparisons, it's difficult to definitively pick a winner, as both aim to simplify workflows for healthcare professionals.

Clinical Value

IM007

Implicity demonstrates a stronger clinical value proposition with published studies showing a 26% reduction in mortality and a 4% decrease in heart failure hospitalizations for patients monitored with their platform. While KardiaPro has FDA-cleared AI for arrhythmia detection and studies indicating reduced urgent healthcare visits, Implicity's data points to more significant, broader patient outcome improvements.

Pricing & Value

Tie

Both Implicity and KardiaPro require contacting them directly for pricing information, indicating a lack of public transparency. Both platforms also mention that their services are reimbursable using existing CPT codes, suggesting similar financial models for healthcare providers. Without specific pricing details, it's impossible to determine which offers better value.

Enterprise Readiness

IM007

Implicity's ability to aggregate data from all major cardiac implantable electronic device (CIED) manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort) into a single platform gives it a significant edge in enterprise readiness. This universal compatibility simplifies integration for large healthcare systems with diverse device populations. KardiaPro primarily integrates with its own KardiaMobile devices and KardiaStation, which, while robust, is less agnostic.

Innovation

IM007

Implicity showcases more advanced AI-driven features, such as AI-driven alert management that significantly reduces false positives (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts) and SignalHF for predictive heart failure hospitalization risk. While KardiaPro offers FDA-cleared AI for arrhythmia detection, Implicity's focus on reducing alert fatigue and providing predictive analytics suggests a higher degree of innovation in addressing critical clinical challenges.

Support & Docs

KardiaPro

KardiaPro provides easily accessible online FAQs and user guides for its various devices and the KardiaPro portal. Implicity's documentation and support resources are not as readily apparent from the provided information, making KardiaPro appear more transparent and user-friendly in this regard.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature IM007 KardiaPro
Company Implicity AliveCor
Tagline The AI-Powered Platform for Remote Cardiac Monitoring Your Partner in Efficient Patient Monitoring and Analysis
Key Features (AI Focus) AI-Driven Alert Management (reduces false positives, e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), ILR ECG Analyzer (FDA-cleared AI for ICM ECG data analysis), SignalHF (FDA-cleared predictive AI for heart failure hospitalization risk) FDA-cleared AI for arrhythmia detection
Data Aggregation/Management Unified Device Data Aggregation (from Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort) ECG, blood pressure, and weight data management; Seamless integration with KardiaMobile and KardiaMobile 6L devices
Specialties Cardiology, Hospital Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring IM007 and KardiaPro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Implicity offers bidirectional API and an integration framework, with an app allowing clinicians to view alerts directly within Epic EHR. KardiaPro also offers EHR integration capabilities through its API and SDK, and is available on Epic's App Orchard Marketplace, enabling seamless access to ECG data within existing workflows.
Implicity's AI-driven alert management significantly reduces false positives, with studies showing a 79% reduction for ILR ECG Analyzer while maintaining 99% sensitivity, and an 85% decrease in unnecessary AF alerts. KardiaPro features FDA-cleared AI for arrhythmia detection, with studies indicating 96.6% sensitivity and 94% specificity for AF detection compared to a cardiology over-read of 12-lead EKGs.
Implicity is designed for comprehensive remote cardiac monitoring, aggregating data from all major CIEDs to streamline workflows for cardiology and heart failure management, including predictive AI for heart failure hospitalization risk (SignalHF). KardiaPro focuses on remote monitoring of ECG, blood pressure, and weight data, integrating with KardiaMobile devices to centralize data for clinical review and trend analysis, supporting general cardiovascular care workflows.
Implicity emphasizes a simple, gradual implementation supported by a Customer Success team, offering targeted training sessions for various staff profiles to ensure smooth and efficient daily use. While KardiaPro is designed for efficient patient monitoring and analysis with a user-friendly interface, specific details on the learning curve or training programs for physicians are not explicitly provided, though its integration with personal ECG devices suggests a focus on ease of use for both patients and providers.
Implicity highlights its multi-centric capabilities and unified platform architecture that supports data ingestion from all major CIED manufacturers, simplifying IT management across multiple sites. KardiaPro's web-based portal and EHR integration capabilities facilitate centralized data review and management, which can support consistent patient care across different locations, though specific multi-site rollout features are not detailed.
Implicity offers a dedicated Customer Success team for onboarding, deployment, hotline support, change management, and regular activity reviews to optimize remote monitoring. KardiaPro provides a web-based portal with resources like user guides and educational materials, and offers customer service via phone and email.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.